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Prevalence and severity of ocular involvement in Graves’ 
disease according to sex and age: A clinical study from 
Babol, Iran 
 
Abstract 
Background: Thyroid-associated eye disease (TED), previously known as Graves’ 
ophthalmopathy is a cosmetically and functionally debilitating disease that is seen 
worldwide. The aim of this study was to evaluate the prevalence and clinical severity of 
ocular manifestations of Graves’ disease according to sex, age and duration in northern 
Iran. 
Methods: Between April 2011 and March 2012, 105 patients with Graves’ disease, 
underwent ophthalmic examination, including ocular motility, exophthalmometry, 
intraocular pressure (IOP), slit lamp and fundoscopy. Patients received scores according to 
modified Werner’s NO SPECS classification. 
Results: Ocular involvement was found in 70 patients with established Graves’s disease. 
The mean age was 35.0 years, (SD 13.0, range 15 to 69). The most common ocular 
findings were exophthalmometric proptosis of more than 20 mm (63.8%), lid lag (55.7%), 
lid retraction (52.8%) and tearing (38.6%). Almost 70% of patients had bilateral 
involvement. Elevated IOP was seen in 15 (25.4%) patients, and was significantly related 
to proptosis (P=0.007). More than half of the patients (n=36, 52.2%) had a modified 
Werner’s NO SPECS score of 3.00. Clinical severity as shown by the increasing number 
of signs and symptoms per patient was correlated to increasing age (r=0.31, P=0.01) but 
not to gender (P=0.17). 
Conclusions: Both functional (ocular motility disorders, increased IOP) and cosmetic 
(proptosis, periorbital edema) sequels are common ocular presentations in patients with 
Graves' disease. Proptosis was the most common finding in this study and was associated 
with elevated IOP. Clinical severity was found to correlate to increasing age. 
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Thyroid-associated eye disease (TED), is a cosmetically disfiguring and functionally 
incapacitating, chronic, infiltrative ocular disease that is usually associated with Graves' 
disease (1). However, it may be seen with other thyroid diseases such as Hashimoto’s 
thyroiditis and thyroid cancer (2). More than 50% of patients with Graves' disease will 
develop mild to severe, unilateral or bilateral TED at some point during the course of their 
disease with severe forms affecting 3% to 5% of patients.  Onset of eye disease is usually 
concomitant with the onset of hyperthyroidism, but ophthalmopathy may precede or 
follow hyperthyroidism and even occur in thyroid or hypothyroid patients (2). TED is seen 
six times more frequently in females than males (86% versus 14% of cases, respectively), 
but the female: male ratio is reduced to 4:1 with severe forms of eye disease (3). The 
Iranian scientist Sayyid Ismail Al-Jurjani first described the relationship between 
exophthalmos and thyroid disease in the 12th century (2, 4).  
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There have been only a few studies on clinical features of 
TED in Iranian patients (5). In order to determine the 
prevalence and severity of ophthalmopathy in Graves' 
patients in the city of Babol in northern Iran, a large number 
of patients with TED were studied, and the influence of 
various factors, such as age, sex and thyroid function, on the 
severity of ophthalmopathy was evaluated. In addition, the 
relative frequencies of our findings were compared and 
contrasted with those of previously reported studies.   
 
 
Methods 
This was a descriptive cross-sectional study. The study 
population included all consecutive patients with confirmed 
diagnosis of Graves' disease who referred to the endocrine 
clinic of Ayatollah Rouhani Hospital in Babol, Iran, from 
April 2011 through March 2012. The diagnosis of Graves' 
disease was based on clinical and laboratory findings of 
diffuse enlargement of thyroid gland, raised free thyroxin or 
triiodothyronine levels, and suppressed thyroid-stimulating 
hormone levels. Information regarding ocular symptoms, 
family history, smoking history, associated systemic disease 
and the treatment regimens were obtained. The study had no 
exclusion criteria and all patients with documented history of 
Graves' disease with any age, onset or type of intervention 
were included. A single ophthalmologist performed ocular 
examinations in all patients. 
A comprehensive ophthalmic examination including 
visual acuity, slit-lamp examination, evaluation of eyelids 
and ocular movements, tonometry with Keeler non-contact 
tonometer, exophthalmometry with Hertel 
exophthalmometer, and fundoscopy for evaluation of optic 
nerve head was performed for all patients. Best-corrected 
visual acuity (BCVA) was documented using Snellen chart. 
Intraocular pressure (IOP) was measured in primary position 
and upward gaze. Retraction of either upper or lower eyelid 
was defined as any exposed superior or inferior sclera 
beyond the limbus in the primary gaze. Proptosis was 
defined as the measurement of antero-posterior protrusion of 
the globe 20 mm or more from the orbital rim in either eye 
or any discrepancy in the degree of protrusion of the two 
eyes by >2 mm (6). Corneal involvement was assessed with 
fluorescein staining under slit lamp microscopy. The relation 
of thyroid size and function with ocular manifestations were 
also evaluated. The classification of TED was based on 
modified Werner’s classification, as endorsed by the 
American Thyroid Association (7) (Table 1). Results were 
analyzed using the SPSS Version 18 (chi squared, Mann 
Whitney u, Spearman, Kruskal-Wallis tests). 
 
Table 1: Modified Werner’s NO SPECS classification of 
eye changes in Graves’ ophthalmopathy 
 
Class Description 
0 No physical signs or symptoms 
1 Only signs, no symptoms (upper lid retraction, stare, 
and eyelid lag) 
2 Soft tissue involvement (symptoms and signs) 
3 Proptosis 
4 Extraocular muscle involvement 
5 Corneal involvement 
6 Sight Loss (optic nerve involvement) 
 
Results  
A total of 105 patients with established Graves' disease 
were studied. 70 patients, 26 (37.1%) males and 44 (62.9 %) 
females, were diagnosed with Graves’ ophthalmopathy 
(GO). The age range was from 15-69 years. The mean age of 
our patients was 35.0 [standard deviation (SD) 13.0]. The 
mean age for females was 33.0±10.7 and for males 
38.1±15.6.  26 (39.4%) patients were under the age 29 years, 
27 (40.9%) patients were between 30-49 years and 13 
(19.7%) patients were between 50-70 years (table 2).  
 
Table 2: Prevalence of signs and symptoms of Graves’ 
ophthalmopathy in different age groups 
 
         Age group 
Variable 
<29 
n=26 
30-49 
n=31 
50-70 
n=13 
Sex 
     male 
     female 
 
10 (38.5) 
16 (36.4) 
 
7 (50) 
11 (36.7) 
 
16 (36.4) 
NO SPECS 
score (mean±SD) 
 
2.4±0.85 
 
2.39±0.84 
 
3.3±1.43 
EOM Limit * 0 0 6 
Increased IOP** n (%) 6 (40) 5 (33.3) 4 (26.7) 
Dry eye n (%) 2 (16.7) 7 (58.3) 3 (25) 
*Extraocular Motility limitation   ** Intraocular Pressure 
 
Overall, in this study, there were more females involved 
with TED than males (F/M=1.7/1). The female to male ratio 
was 1.6 and 2.25 in the younger and the middle age groups 
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respectively, but was 0.6 in the older age group. Even though 
in the older age group there were more males than females, 8 
(61.5%) to 5 (38.5%), this reversal of ratio in older patients 
was not significant (P=0.17).  
The most common ocular finding in this study was 
proptosis in 44 (63.8%) patients that was unilateral in 14 
(31.8%) and bilateral in 30 (68.2%). The next common 
finding was lid lag in 39 (55.7%) patients, of which 10 
(14.3%) were unilateral and 29 (41.4%) were bilateral, and 
lid retraction in 37 (52.8%) patients of which 29 (41.4%) 
were bilateral. Other signs and symptoms include tearing in 
27 (38.6%), eyelid swelling in 23 (32.9%), conjunctival 
injection 21 (30%), ocular pain in 18 (25.7%) and dry eye in 
12 (17.1%). Not all findings were similar in men and 
women: eyelid swelling (42.3%) and conjunctival injection 
(53.8%) was more frequent in males whereas ocular pain 
(32.6%) and dry eye (20.5%) were seen more in females (fig 
1). Ophthalmopathy was classified according to modified 
Werner’s NO SPECS classification score (table 1). The 
majority of patients (n=37, 52.9%) had a score of 3, followed 
by score of 2 (n=15, 21.4%) and score of 1 (n=12, 17.1%) 
and only 6 (8.6%) patients were 4 or higher (fig 2). There 
was no significant difference in the scores according to sex 
(P=0.57) or increasing age (P=0.068). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: Prevalence of ocular signs and symptoms in 70 
patients with Graves’ ophthalmopathy by gender 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2: Distribution of 70 patients with Graves’ 
ophthalmopathy according to NO SPECS score. 
 
The mean NO SPECS score for males was 2.69±1.01, 
and for females 2.52±1.04 but the difference was not found 
to be significant (P=0.5). The average number of ocular 
signs and symptoms per patient was 4.1 in those younger 
than 29 years, 4.0 in those between 30-49 years, and 6.7 in 
those above 50 years (table 2). This difference was clinically 
significant (P= 0.004). 
The average number of signs and symptoms was greater 
in males (5.15) than females (4.27), (P=0.17). Clinical 
severity, as judged by the increasing number of signs and 
symptoms, was correlated to increasing age (r=0.31, 
P=0.01). Elevated IOP was seen in 15 (25.4%) patients, 9 
(37.5%) males and 6 (17%) females, however the sex 
difference was not found to be significant (P=0.07). There 
were 13 (39.4%) patients with proptosis and increased IOP. 
There was a positive correlation between increased IOP and 
exophthalmos (P=0.007) chi squared test. Also, there was a 
positive correlation between increased IOP and severity of 
disease. In patients with increased IOP, the mean NO SPECS 
score was 3.13 and the median was 3. In patients with 
normal IOP mean NO SPECS was 2.3 and the median was 2. 
This difference was significant (P=0.029). 
Patients with elevated IOP had a greater number of signs 
and symptoms (4.9±2.1) compared to those with normal IOP 
(4.8±2.7) but the difference was not significant (P= 0.9) 
(table 2). Limitation of extraocular motility and deviation of 
the eyes were seen in 6 of our patients, 3 (6.8%) females and 
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3 males (11.5%). All 6 patients were above 50 years of age. 
Clinical evidence of dry eye was seen in 12 (17.1%) patients, 
3 (25%) males and 9 (75%) females. Foreign body sensation 
was present in 13 (18.6%) of patients. There was a positive 
correlation between symptoms of foreign body sensation and 
clinical evidence of dry eye (P=0.039). However proptosis 
was not related to dry eye (P=0.74) or foreign body sensation 
(P=0.34). 
In 65% of patients, the presence of TED was concurrent 
or within 6 months of diagnosis of thyroid disease, 20% 
between 7-24 months and 15% more than 24 months. There 
was no correlation between duration of disease and proptosis 
(P=0.47) or clinical severity (P=0.84). We had only two 
smokers in this study who were both males. In this study, 
there was only one patient with unilateral pallor of the optic 
disc due to compressive optic neuropathy and one case of 
bilateral venous congestion of the optic nerve head. Both 
patients were males and more than 50 years old. We had no 
cases of sight loss due to corneal opacification. 
 
 
Discussion 
Involvement of the eyes in thyroid disease is a well-
known entity. In this study, our aim was to find the relative 
frequencies of various presenting signs and symptoms of 
TED in a patient population in northern Iran based on 
different age groups and gender. Most studies around the 
world have shown a higher female to male ratio (3, 8). In our 
study, we had a female to male ratio of 1.7 to 1. Besharati 
(5), Etezad-Razavi (9) and Perros (10) also showed a higher 
frequency in females but Kashkouli et al. (11) reported more 
prevalent thyroid eye disease in males.  
More than 80% of our patients were under the age 50. 
Similarly in a study by Besharati (5), 85.3% of patients were 
below 50 years old. In most studies, the mean age of 
involvement with TED was lower in females than males. 
Etezad-Razavi reported a mean of 34.7 years for females and 
44.7 years for males, which is slightly different from our 
mean of 33.0 and 38.1 years for females and males, 
respectively. Lee (12) found a mean of 43.9 years in males 
and 44.4 years in females, while Perros (10) reported an 
overall higher mean age of involvement in his patients 
49.2±13.4 years. The more severe forms of TED were seen 
in our male population, even though our results were not 
clinically significant (P=0.06). Jafari et al. (13), Lee et al. 
(12) and Perros (10) reported a similar finding of increasing 
severity in male population.  
The majority of our patients had NO SPECS score or 3 or 
less which was similar to other studies (3, 9). There was an 
increasing number of individual signs and symptoms with 
increasing age, showing that older patients tend to develop 
more severe forms of TED (p=0.004). The studies by 
Besharati (5), Perros (10) and Lee (12) also demonstrated 
this trend. It appears that even though TED is more 
frequently seen in females, a more aggressive form is seen 
with increasing age and the male gender (14). 
Proptosis was the most common finding in our series 
(63.8%), followed by lid lag (55.7%), and lid retraction 
(52.8%). Etezad-Razavi (9) reported lid retraction (64.2%), 
proptosis (53%) and lid lag (28.1%). Besharati (5) showed 
proptosis in 52%, lid retraction in 48.5%, and lid lag in 
42.2%. Limitation of ocular motility and eye deviation was 
seen in 8.6% of our patients. Studies in other parts of Iran 
have reported restricted motility ranging from 13.3% to 
41.3% (9, 11, 13). This wide range of clinical manifestation 
may represent ethnic or regional differences in the patient 
population. Also the earlier presentation of patients leading 
to earlier diagnosis and treatment could be a cause of this 
variability. In a study by Lim et al., it was shown that 
proptosis and muscle involvement was less pronounced in 
Asian patients as compared to other ethnic groups (15).   
One notable finding in this study was elevation of IOP. 
The orbit is a bony structure and any increase in intraorbital 
volume will cause both displacement of the globe anteriorly 
and increased intraocular pressure (16). The association of 
thyroid eye disease with increased IOP has been known for 
more than a century (17). Increased IOP in up gaze is 
commonly seen in TED, however it is not specific to TED, 
and can be seen in any infiltrative orbitopathy due to 
mechanical compression of the globe (16) In addition, it has 
been proposed that thyroid related ocular hypertension may 
be caused by increased episcleral venous pressure or 
glycosaminoglycan deposition in the trabecular meshwork 
(16).  
In a study by Haefliger et al. in 1997 (18), performed on 
500 patient charts, the prevalence of increased IOP was 
noted to be 24%.  In 2007, Behrouzi et al. (19) reported a 
prevalence of 11%, and He et al. reported an incidence of 
31.3% in Chinese patients (20). With persistence of 
exophthalmos, there was an increased chance of 
development and progression of glaucoma signs such as 
cupping of the disc and visual field defects (20). 
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In our study, we had 15 (25.4%) cases of increased IOP 
in primary position. Increase in IOP can be explained by 
increased pressure on the globe by enlarging muscle masses 
and by impediment of episcleral outflow. Indeed in our 
study, there was a strong correlation between proptosis and 
increase IOP (P=0.007). Increased IOP was seen more in 
men (37.5%) than women (17.1%), P=0.078. Persistence of 
TED may lead to progressive increase of IOP, leading to 
overt manifestations of glaucoma such as cupping of the disc 
and visual field loss (18), therefore, follow-up of patients in 
this regard is warranted. 
Dry eye has historically been explained by increased tear 
evaporation from proptotic eyes (21). Nonetheless recently it 
has been shown that the lacrimal gland may also be a target 
of TSH antibodies (22). Clinical evidence of dry eye was 
noted in 12 (17.1%) of our patients. When dry eye was 
cross-referenced with presence of proptosis, it was not found 
to be significant (P=0.74), indicating that lacrimal gland 
dysfunction should be considered as an entity by itself and 
not merely a consequence of proptosis. Interestingly, it has 
been shown by Gupta et al. that in patients presenting with 
dry eyes, previously undiagnosed thyroid dysfunction may 
be the underlying cause (23). 
In our study, we had one case of compressive optic 
neuropathy that presented with pale discs (2.8%). This 
patient had severe proptosis, limitation of ocular motility, 
increased IOP, and periorbital swelling. Kashkouli et al. (11) 
reported optic nerve involvement in 6.3% of their patients. It 
has been shown that compressive optic neuropathy is highly 
correlated to extraocular muscle fibrosis and limitation of 
movement (24). We did not have enough cases to evaluate 
this fact independently. 
Smoking has been shown to correlate with the severity of 
TED (25). In our patient population, there were only 2 
smokers both of who had severe TED, yet there was not 
enough data to make a statistical statement in this study. In 
conclusion, we found that ocular manifestations of Graves' 
are quite common. Proptosis was the most common ocular 
finding in this study followed by lid lag and lid retraction. 
More than 80% of our patients were below age 50, but more 
severe forms of the disease were seen in older age groups. 
Dry eye and increased IOP are commonly seen outcomes 
that should be managed diligently. This potentially sight-
threatening condition is seen worldwide and has many 
functional and cosmetic consequences that need to be 
recognized. 
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